早期假体周围关节感染清创、抗生素及假体保留的时机:来自芬兰关节置换登记处的数据
基于芬兰关节置换登记处2014年5月至2022年4月178,498例初次全髋/全膝关节置换术数据,分析1,014例术后6个月内行清创、抗生素及假体保留(DAIR)的失败率。全髋组DAIR失败率在术后0-42天为15.1%、43-84天为10.0%、85-180天为31.4%;全膝组分别为8.9%、16.7%、9.8%。与0-42天相比,较晚行DAIR未增加再翻修风险。结论认为DAIR在术后6周后实施时失败率可能不会如既往认为的那样增加,DAIR可考虑用于术后6周以上的假体周围关节感染。
要点
- 全髋组DAIR失败率:0-42天15.1%,43-84天10.0%,85-180天31.4%。
- 全膝组DAIR失败率:0-42天8.9%,43-84天16.7%,85-180天9.8%。
- 与0-42天相比,较晚行DAIR未增加再翻修风险(全髋43-84天HR 1.2,85-180天HR 1.4;全膝43-84天HR 1.0,85-180天HR 1.9,95%CI均跨1)。
核心结论
- DAIR失败率在初次全关节置换术后6周以后实施时可能不会如既往认为的那样增加。
- 因此,DAIR也可考虑作为术后6周以上假体周围关节感染的治疗方法,取决于病例的严重程度。
研究设计与样本
- 基于芬兰关节置换登记处(FAR)2014年5月至2022年4月记录的178,498例初次手术(78,888例全髋关节置换术和99,610例全膝关节置换术)。
- 全髋组男性占53.4%,全膝组男性占55.5%;全髋组最常见年龄组为≤62岁,全膝组为≥76岁;所有患者均为芬兰族裔。
- 共1,014例DAIR在初次关节置换术后6个月内实施;DAIR后因假体周围关节感染在1年内再翻修视为DAIR治疗失败。
- 比较术后0-42天、43-84天和85-180天3个时间间隔的DAIR失败率,采用Cox回归模型评估再翻修风险因素。
- 证据等级:治疗性III级。
主要发现
- 全髋组DAIR失败率:0-42天为15.1%,43-84天为10.0%,85-180天为31.4%。
- 全膝组DAIR失败率:0-42天为8.9%,43-84天为16.7%,85-180天为9.8%。
- 全髋组与0-42天参照相比,43-84天再翻修风险HR 1.2(95%CI 0.6-2.2;p=0.63),85-180天HR 1.4(95%CI 0.6-3.0;p=0.41),均未达统计学显著。
- 全膝组与0-42天参照相比,43-84天HR 1.0(95%CI 0.4-2.4;p=0.98),85-180天HR 1.9(95%CI 1.0-3.8;p=0.065),均未达统计学显著。
临床怎么用
- 作者认为,DAIR也可考虑作为术后6周以上假体周围关节感染的治疗方法,取决于病例的严重程度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Debridement, antibiotics, and implant retention (DAIR) is the method of choice in the treatment of acute periprosthetic joint infection (PJI). However, the optimal timing of DAIR is somewhat unclear. We assessed the success of DAIR performed during different time intervals after primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) using data from the Finnish Arthroplasty Register (FAR). METHODS: There were 178,498 primary operations (78,888 THAs and 99,610 TKAs) from May 2014 to April 2022 recorded in the FAR. Male patients represented 53.4% of the THA group and 55.5% of the TKA group. The most common age group was ≤62 years in the THA group and ≥76 years in the TKA group. All patients were of Finnish ethnicity. A total of 1,014 DAIR procedures were performed within 6 months after the primary arthroplasty. Cases of reoperation after DAIR were followed for 1 year after the DAIR; re-revision due to PJI within 1 year was regarded as a failure of the DAIR treatment. We compared the failure rate of DAIR among 3 time intervals: 0 to 42, 43 to 84, and 85 to 180 days after the primary operation. A Cox regression model was used to assess risk factors for re-revision. RESULTS: In the THA group, the failure rate was 15.1% when DAIR was performed within 42 days, 10.0% when performed at 43 to 84 days, and 31.4% when performed at 85 to 180 days after the primary THA. In the TKA group, the failure rate was 8.9% when DAIR was performed within 42 days, 16.7% when performed at 43 to 84 days, and 9.8% when performed at 85 to 180 days after the primary TKA. Later DAIR was not associated with an increased re-revision risk, compared with the reference of 0 to 42 days, in the THA group (43 to 84 days: hazard ratio [HR], 1.2 [95% confidence interval (CI), 0.6 to 2.2; p = 0.63]; 85 to 180 days: HR, 1.4 [95% CI, 0.6 to 3.0; p = 0.41]). The same was true in the TKA group (43 to 84 days: HR, 1.0 [95% CI, 0.4 to 2.4; p = 0.98]; 85 to 180 days: HR, 1.9 [95% CI, 1.0 to 3.8; p = 0.065]). CONCLUSIONS: The failure rate of DAIR may not increase as much as previously thought if performed >6 weeks after primary total joint arthroplasty. Thus, DAIR can also be worth considering as a treatment method for PJI beyond the first 6 weeks postoperatively, depending on the severity of the case. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Keemu H, Syystö E, Klén R, et al. Timing of Debridement, Antibiotics, and Implant Retention for Early Periprosthetic Joint Infection: Data from the Finnish Arthroplasty Register. J Bone Joint Surg Am. 2025. PMID: 41315041. doi:10.2106/JBJS.25.00946
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。